Cornea/External Disease News

Ophthalmologists must work with oncologists to understand and mitigate ocular surface adverse events caused by oncologic therapeutics, according to a presentation at Real World Ophthalmology.

Over the last several years, I have come to learn why treating dry eye is so important for our patients.

I discussed the projected future U.S. health care system shortage of ophthalmologists in my Lindstrom’s Perspective in the Jan. 25, 2024, issue.

An impending physician shortage has been hanging over ophthalmology for years. The aging population needs more eye care, but as ophthalmologists are aging with that population, there are not enough incoming physicians to take their place.

You know, I really thought that significant gains had been made in raising the awareness of both the prevalence of and the need to treat dry eye disease in the perioperative period for cataract and refractive surgeries.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Ever heard of a helical collagen intercalator? How about a TRPM8 agonist? Maybe RASP as a target of treatment?

Penetrating keratoplasty is an effective procedure that can restore sight for patients. However, it is not without significant risks and burdens, especially for young people who may need a second or even third graft during their lifetime.

Ophthalmologists can attend interactive sessions, network with colleagues and earn CME credits at this year’s Kiawah Eye, organized by Healio Live.

More than half of patients with type 2 diabetic nephropathy had dry eye disease, which was independently associated with older age, high HbA1C and reduced glomerular filtration rate, according to research conducted in Vietnam.